Immediate Impact
4 from Science/Nature 54 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Daniel von Allmen being referenced
Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel von Allmen | 1012 | 445 | 273 | 92 | 1.9k | |
| Timothy B. Lautz | 1237 | 502 | 206 | 128 | 2.2k | |
| Peter Mattei | 932 | 402 | 82 | 81 | 1.6k | |
| Deborah F. Billmire | 1931 | 489 | 387 | 96 | 2.5k | |
| Richard D. Bellah | 910 | 305 | 65 | 80 | 1.6k | |
| Arbay Ö. Çiftçi | 1310 | 527 | 107 | 104 | 2.0k | |
| Lester W. Martin | 1923 | 504 | 269 | 102 | 2.7k | |
| Bernhard Glodny | 871 | 834 | 167 | 128 | 2.4k | |
| M.J. Weston | 1143 | 512 | 72 | 120 | 2.9k | |
| Mikko Hippeläinen | 1004 | 355 | 118 | 72 | 2.5k | |
| Rakesh Sinha | 918 | 295 | 84 | 95 | 1.9k |
All Works
Loading papers...